Skip to main content
Top
Published in: Health Research Policy and Systems 1/2012

Open Access 01-12-2012 | Review

Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda

Authors: Stefanie E O Meredith, Catherine Cross, Uche V Amazigo

Published in: Health Research Policy and Systems | Issue 1/2012

Login to get access

Abstract

The control of onchocerciasis is not only a major success story in global health, but also one of the best examples of the power of public-private partnership at the international level as well as at the national level. The onchocerciasis story is also a leading example of the contribution of a group of called Non-Governmental Development Organizations (NGDO) to operational research which resulted in important changes in treatment strategies and policies.
The four case studies presented here illustrate some key contributions the NGDOs made to the development of “community directed treatment with ivermectin” –CDTI, in Africa, which became the approved methodology within the African Programme for Onchocerciasis Control (APOC). The partnership between the international, multilateral, government institutions and the NGDO Coordination Group was the backbone of the APOC programme’s structure and facilitated progress and scale-up of treatment programmes. Contributions included piloting community–based methodology in Mali and Nigeria; research, collaboration and coordination on treatment strategies and policies, coalition building, capacity building of national health workforce and advocacy at the national and international level. While the Onchocerciasis Control Programme (OCP) and APOC provided leadership, the NGDOs working with the national health authorities played a major role in advocacy evolving the community methodology which led to achieving and maintaining- treatments with ivermectin for at least 20 years and strengthening community health systems.
Appendix
Available only for authorised users
Literature
1.
go back to reference Benton B, Bump J, Sékétéli A, Liese B: Partnership and promise: evolution of the African river-blindness campaigns. Ann Trop Med Parasitol. 2002, 96 (Suppl 1): S5-S14.CrossRefPubMed Benton B, Bump J, Sékétéli A, Liese B: Partnership and promise: evolution of the African river-blindness campaigns. Ann Trop Med Parasitol. 2002, 96 (Suppl 1): S5-S14.CrossRefPubMed
2.
go back to reference Boatin B: The Onchocerciasis Control Programme in West Africa (OCP). Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 13-17.CrossRefPubMed Boatin B: The Onchocerciasis Control Programme in West Africa (OCP). Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 13-17.CrossRefPubMed
3.
go back to reference Levine R: Millions Saved. Controlling onchcocerciais in Sub-Saharan-Africa. Edited by: Danvers R Levine. 2007, Burlinton: Jones and Bartlett Levine R: Millions Saved. Controlling onchcocerciais in Sub-Saharan-Africa. Edited by: Danvers R Levine. 2007, Burlinton: Jones and Bartlett
4.
go back to reference Bush S, Hopkins AD: Public-private partnerships in neglected tropical disease control: the role of non- governmental organisations. Acta Trop. 2011, 120 (Suppl 1): S169-S172.CrossRefPubMed Bush S, Hopkins AD: Public-private partnerships in neglected tropical disease control: the role of non- governmental organisations. Acta Trop. 2011, 120 (Suppl 1): S169-S172.CrossRefPubMed
5.
go back to reference Remme JHF, Feenstra P, Lever PR, Medici AC, Morel CM, Noma M, Ramaiah KD, Richards F, Sékétéli A, Schmunis G: Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy. Disease Control Priorities in Developing Countries. Edited by: Jamison DT. 2006, Washington DC: The International Bank for Reconstruction and Development/The World Bank Group Remme JHF, Feenstra P, Lever PR, Medici AC, Morel CM, Noma M, Ramaiah KD, Richards F, Sékétéli A, Schmunis G: Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy. Disease Control Priorities in Developing Countries. Edited by: Jamison DT. 2006, Washington DC: The International Bank for Reconstruction and Development/The World Bank Group
6.
go back to reference Kim A: Health and Labour Productivity: the economic impact of onchocercal skin disease: Policy and research working paper 1836. 1997, Washington: The World Bank Kim A: Health and Labour Productivity: the economic impact of onchocercal skin disease: Policy and research working paper 1836. 1997, Washington: The World Bank
7.
go back to reference WHO: Onchocerciasis and its Control. In: WHO technical report series. 1995, Geneva: World Health Organization WHO: Onchocerciasis and its Control. In: WHO technical report series. 1995, Geneva: World Health Organization
8.
go back to reference Samba EM: The Onchocerciais Control Programme in West Africa. 1994, Geneva: World Health Organization Samba EM: The Onchocerciais Control Programme in West Africa. 1994, Geneva: World Health Organization
9.
go back to reference Sturchio J: Business engagement in public programs: the pharmaceutical industry's contribution to public health and the millennium development goals. 2008, Bingley: Emerald Group Publishing Limited Sturchio J: Business engagement in public programs: the pharmaceutical industry's contribution to public health and the millennium development goals. 2008, Bingley: Emerald Group Publishing Limited
10.
go back to reference Haddad D, Cross C, Thylefors B, Richards FO: Bush S, Hopkins AD, Baker SK: Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control. Glob Public Health. 2008, 3 (2): 187-196.CrossRefPubMed Haddad D, Cross C, Thylefors B, Richards FO: Bush S, Hopkins AD, Baker SK: Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control. Glob Public Health. 2008, 3 (2): 187-196.CrossRefPubMed
11.
go back to reference Newland HS, White AT, Greene BM, D'Anna SA, Keyvan-Larijani E, Aziz MA, Williams PN, Taylor HR: Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. Br J Ophthalmol. 1988, 72 (8): 561-569.CrossRefPubMedPubMedCentral Newland HS, White AT, Greene BM, D'Anna SA, Keyvan-Larijani E, Aziz MA, Williams PN, Taylor HR: Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. Br J Ophthalmol. 1988, 72 (8): 561-569.CrossRefPubMedPubMedCentral
12.
go back to reference Greene BM, White AT, Newland HS, Keyvan-Larijani E, Dukuly ZD, Gallin MY, Aziz MA, Williams PN, Taylor HR: Single dose therapy with ivermectin for onchocerciasis. Trans Assoc Am Physicians. 1987, 100: 131-138.PubMed Greene BM, White AT, Newland HS, Keyvan-Larijani E, Dukuly ZD, Gallin MY, Aziz MA, Williams PN, Taylor HR: Single dose therapy with ivermectin for onchocerciasis. Trans Assoc Am Physicians. 1987, 100: 131-138.PubMed
13.
go back to reference Pacque MC, Dukuly Z, Greene BM, Munoz B, Keyvan-Larijani E, Williams PN, Taylor HR: Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions. Bull World Health Organ. 1989, 67 (6): 721-730.PubMedPubMedCentral Pacque MC, Dukuly Z, Greene BM, Munoz B, Keyvan-Larijani E, Williams PN, Taylor HR: Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions. Bull World Health Organ. 1989, 67 (6): 721-730.PubMedPubMedCentral
14.
go back to reference WHO: The Importance of Onchocercal Skin Disease: Report of a multi-country study by the Pan-African Study Group in Onchocercal Skin Disease. 1995, Geneva: The World Health Organization WHO: The Importance of Onchocercal Skin Disease: Report of a multi-country study by the Pan-African Study Group in Onchocercal Skin Disease. 1995, Geneva: The World Health Organization
15.
go back to reference Amazigo UO: Detrimental effects of onchocerciasis on marriage age and breast-feeding. Trop Geogr Med. 1994, 46 (5): 322-325.PubMed Amazigo UO: Detrimental effects of onchocerciasis on marriage age and breast-feeding. Trop Geogr Med. 1994, 46 (5): 322-325.PubMed
17.
go back to reference Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, Kuete T, Ndyomugyenyi R, Onapa A, Salifou M: After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Tropical medicine & international health : TM & IH. 2008, 13 (9): 1196-1203.CrossRef Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, Kuete T, Ndyomugyenyi R, Onapa A, Salifou M: After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Tropical medicine & international health : TM & IH. 2008, 13 (9): 1196-1203.CrossRef
18.
go back to reference Teckle EH AH, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S, Abiose A, Remme JH: Impact of long-term treatmentt of onchocerciasis with ivermectin in Kaduna state, Nigeria: first evidence of the potential for elimination in the operationa area of the African Programme for Onchocerciais Control. Parasite and Vector. 2012, 5: 28-CrossRef Teckle EH AH, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S, Abiose A, Remme JH: Impact of long-term treatmentt of onchocerciasis with ivermectin in Kaduna state, Nigeria: first evidence of the potential for elimination in the operationa area of the African Programme for Onchocerciais Control. Parasite and Vector. 2012, 5: 28-CrossRef
19.
go back to reference Haddad D: The NGDO Co-ordination Group for Onchocerciasis Control. Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 35-38.CrossRefPubMed Haddad D: The NGDO Co-ordination Group for Onchocerciasis Control. Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 35-38.CrossRefPubMed
20.
go back to reference Amazigo U: The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 19-22.CrossRefPubMed Amazigo U: The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 19-22.CrossRefPubMed
21.
go back to reference Dadzie KY: Onchocerciasis control: the APOC strategy. Africa health. 1997, 19 (3): 13-15.PubMed Dadzie KY: Onchocerciasis control: the APOC strategy. Africa health. 1997, 19 (3): 13-15.PubMed
22.
go back to reference Drameh PS, Richards FO, Cross C, Etya'ale DE, Kassalow JS: Ten years of NGDO action against river blindness. Trends Parasitol. 2002, 18 (9): 378-380.CrossRefPubMed Drameh PS, Richards FO, Cross C, Etya'ale DE, Kassalow JS: Ten years of NGDO action against river blindness. Trends Parasitol. 2002, 18 (9): 378-380.CrossRefPubMed
23.
go back to reference Sauerbrey M: The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 25-29.CrossRefPubMed Sauerbrey M: The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol. 2008, 102 (Suppl 1): 25-29.CrossRefPubMed
24.
go back to reference Delisle H, Roberts J, Munro M, Jones L, Gyorkos T: The role of NGOs in global health research for development. Health Research Policy and Systems. 2005, 3 (1): 3-CrossRefPubMedPubMedCentral Delisle H, Roberts J, Munro M, Jones L, Gyorkos T: The role of NGOs in global health research for development. Health Research Policy and Systems. 2005, 3 (1): 3-CrossRefPubMedPubMedCentral
25.
go back to reference Lavis JN, Robertson D, Woodside JM, McLeod CB, Abelson J: How can research organizations more effectively transfer research knowledge to decision makers?. Milbank Q. 2003, 81 (2): 221-248. 171–222CrossRefPubMedPubMedCentral Lavis JN, Robertson D, Woodside JM, McLeod CB, Abelson J: How can research organizations more effectively transfer research knowledge to decision makers?. Milbank Q. 2003, 81 (2): 221-248. 171–222CrossRefPubMedPubMedCentral
26.
go back to reference Seketeli A, Adeoye G, Eyamba A, Nnoruka E, Drameh P, Amazigo UV, Noma M, Agboton F, Aholou Y, Kale OO: The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002, 96 (Suppl 1): S15-28.CrossRefPubMed Seketeli A, Adeoye G, Eyamba A, Nnoruka E, Drameh P, Amazigo UV, Noma M, Agboton F, Aholou Y, Kale OO: The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002, 96 (Suppl 1): S15-28.CrossRefPubMed
27.
go back to reference Alexander ND, Cousens SN, Yahaya H, Abiose A, Jones BR: Ivermectin dose assessment without weighing scales. Bull World Health Organ. 1993, 71 (3–4): 361-366.PubMedPubMedCentral Alexander ND, Cousens SN, Yahaya H, Abiose A, Jones BR: Ivermectin dose assessment without weighing scales. Bull World Health Organ. 1993, 71 (3–4): 361-366.PubMedPubMedCentral
28.
go back to reference WHO: Community Directed Treatment with Ivermectin. 1996, Geneva: WHO WHO: Community Directed Treatment with Ivermectin. 1996, Geneva: WHO
29.
go back to reference Rougemont A, Boisson ME: Borges da Silva G, Zander N: [Attempt at a collective treatment with diethylcarbamazine in a village in the region of Bamako (Mali) where onchocerciasis is hyperendemic]. Bull World Health Organ. 1976, 54 (4): 403-410.PubMedPubMedCentral Rougemont A, Boisson ME: Borges da Silva G, Zander N: [Attempt at a collective treatment with diethylcarbamazine in a village in the region of Bamako (Mali) where onchocerciasis is hyperendemic]. Bull World Health Organ. 1976, 54 (4): 403-410.PubMedPubMedCentral
30.
go back to reference De Sole G: Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution. Trans R Soc Trop Med Hyg. 1995, 89 (2): 224-225.CrossRefPubMed De Sole G: Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution. Trans R Soc Trop Med Hyg. 1995, 89 (2): 224-225.CrossRefPubMed
31.
go back to reference Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konate L, Mounkoro K, Sarr MD, Seck AF: Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009, 3 (7): e497-CrossRefPubMedPubMedCentral Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konate L, Mounkoro K, Sarr MD, Seck AF: Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009, 3 (7): e497-CrossRefPubMedPubMedCentral
32.
go back to reference Budden FH: The epidemiology of onchocerciasis in Northern Nigeria. Trans R Soc Trop Med Hyg. 1956, 50 (4): 366-378.CrossRefPubMed Budden FH: The epidemiology of onchocerciasis in Northern Nigeria. Trans R Soc Trop Med Hyg. 1956, 50 (4): 366-378.CrossRefPubMed
34.
go back to reference Ogbuagu KF, Eneanya CI: A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings. Ann Trop Med Parasitol. 1998, 92 (Suppl 1): S139-145.PubMed Ogbuagu KF, Eneanya CI: A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings. Ann Trop Med Parasitol. 1998, 92 (Suppl 1): S139-145.PubMed
35.
go back to reference Brieger WR, Awedoba AK, Eneanya CI, Hagan M, Ogbuagu KF, Okello DO, Ososanya OO, Ovuga EB, Noma M, Kale OO: The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Tropical medicine & international health : TM & IH. 1998, 3 (12): 951-961.CrossRef Brieger WR, Awedoba AK, Eneanya CI, Hagan M, Ogbuagu KF, Okello DO, Ososanya OO, Ovuga EB, Noma M, Kale OO: The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Tropical medicine & international health : TM & IH. 1998, 3 (12): 951-961.CrossRef
36.
go back to reference Njepuome PO-P N, Okoronkwo C, Igbe M: Controlling Onchocerciasis: The Nigerian Experience. The Internet Journal of Parasitic Diseases. 2009, Volume 4 (Number 1): - Njepuome PO-P N, Okoronkwo C, Igbe M: Controlling Onchocerciasis: The Nigerian Experience. The Internet Journal of Parasitic Diseases. 2009, Volume 4 (Number 1): -
37.
go back to reference Khemani S: Local Government accountability for health service delivery in Nigeria. Journal of African Economics. 2005, 15 (2): 285-312.CrossRef Khemani S: Local Government accountability for health service delivery in Nigeria. Journal of African Economics. 2005, 15 (2): 285-312.CrossRef
38.
go back to reference Duke BO, Lewis DJ, Moore PJ: Onchocerca-Simulium complexes. I. Transmission of forest and Sudan-savanna strains of Onchocerca volvulus, from Cameroon, by Simulium damnosum from various West African bioclimatic zones. Ann Trop Med Parasitol. 1966, 60 (3): 318-326.CrossRefPubMed Duke BO, Lewis DJ, Moore PJ: Onchocerca-Simulium complexes. I. Transmission of forest and Sudan-savanna strains of Onchocerca volvulus, from Cameroon, by Simulium damnosum from various West African bioclimatic zones. Ann Trop Med Parasitol. 1966, 60 (3): 318-326.CrossRefPubMed
39.
go back to reference Fuglsang H, Anderson J, Marshall TF: Studies on onchocerciasis in the United Cameroon Republic. V.A. four year follow-up of 6 rain-forest and 6-Sudan-savanna villages. Some changes in skin and lymph . nodesTransactions of the Royal Society of Tropical Medicine and Hygiene. 1979, 73 (1): 118-119.CrossRef Fuglsang H, Anderson J, Marshall TF: Studies on onchocerciasis in the United Cameroon Republic. V.A. four year follow-up of 6 rain-forest and 6-Sudan-savanna villages. Some changes in skin and lymph . nodesTransactions of the Royal Society of Tropical Medicine and Hygiene. 1979, 73 (1): 118-119.CrossRef
40.
go back to reference Renz A, Wenk P, Anderson J, Fuglsang H: Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon V. What is a tolerable level of Annual Transmission Potential?. Ann Trop Med Parasitol. 1987, 81 (3): 263-274.PubMed Renz A, Wenk P, Anderson J, Fuglsang H: Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon V. What is a tolerable level of Annual Transmission Potential?. Ann Trop Med Parasitol. 1987, 81 (3): 263-274.PubMed
41.
go back to reference Ngoumou P, Walsh JF, Mace JM: A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol. 1994, 88 (5): 463-474.PubMed Ngoumou P, Walsh JF, Mace JM: A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol. 1994, 88 (5): 463-474.PubMed
42.
go back to reference Mace JM, Boussinesq M, Ngoumou P, Oye J Enyegue, Koeranga A, Godin C: Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon. Ann Trop Med Parasitol. 1997, 91 (4): 379-391.CrossRefPubMed Mace JM, Boussinesq M, Ngoumou P, Oye J Enyegue, Koeranga A, Godin C: Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon. Ann Trop Med Parasitol. 1997, 91 (4): 379-391.CrossRefPubMed
43.
go back to reference Twum-Danso NA, Meredith SE: Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis. Tropical medicine & international health : TM & IH. 2003, 8 (9): 820-831.CrossRef Twum-Danso NA, Meredith SE: Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis. Tropical medicine & international health : TM & IH. 2003, 8 (9): 820-831.CrossRef
44.
go back to reference Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC: Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitology today (Personal ed). 1996, 12 (11): 448-450.CrossRef Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC: Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitology today (Personal ed). 1996, 12 (11): 448-450.CrossRef
45.
go back to reference Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M: Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997, 350 (9070): 18-22.CrossRefPubMed Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M: Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997, 350 (9070): 18-22.CrossRefPubMed
46.
go back to reference Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P: Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria journal. 2005, 4 (1): 2-CrossRefPubMedPubMedCentral Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P: Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria journal. 2005, 4 (1): 2-CrossRefPubMedPubMedCentral
47.
go back to reference Fischer P, Kipp W, Bamuhiga J, Binta-Kahwa J, Kiefer A, Buttner DW: Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ). 1993, 44 (4): 311-321. Fischer P, Kipp W, Bamuhiga J, Binta-Kahwa J, Kiefer A, Buttner DW: Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ). 1993, 44 (4): 311-321.
48.
go back to reference Cupp EW, Guyer C, Sprenger TR, Unnasch TR: Importance of ivermectin to human onchocerciasis:past, present and the future. Research and reports in Tropical medicine. 2011, 2: 81-92.CrossRef Cupp EW, Guyer C, Sprenger TR, Unnasch TR: Importance of ivermectin to human onchocerciasis:past, present and the future. Research and reports in Tropical medicine. 2011, 2: 81-92.CrossRef
49.
go back to reference Coffeng GF LE, Ozoh G, Bissek AC, Niatté BO, Enyong P, Olinga Olinga BM, Zouré HGM, Habbema JDF, Stolk WA, de Vlas SJ, Boussinesq M, Noma M: Concurrence of dermatological and ophthalmological morbidity in onchocerciasis. Trans R Soc Trop Med Hyg. 2012, 106 (4): 245-251.CrossRef Coffeng GF LE, Ozoh G, Bissek AC, Niatté BO, Enyong P, Olinga Olinga BM, Zouré HGM, Habbema JDF, Stolk WA, de Vlas SJ, Boussinesq M, Noma M: Concurrence of dermatological and ophthalmological morbidity in onchocerciasis. Trans R Soc Trop Med Hyg. 2012, 106 (4): 245-251.CrossRef
Metadata
Title
Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda
Authors
Stefanie E O Meredith
Catherine Cross
Uche V Amazigo
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2012
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/1478-4505-10-16

Other articles of this Issue 1/2012

Health Research Policy and Systems 1/2012 Go to the issue